In terms of SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated 2nd July 2025, Krebs Biochemicals & Industries has informed that it enclosed report dated November 17, 2025 received from the Registrar and Share Transfer Agent of the Company, KFIN Technologies on re-lodgement of transfer requests of physical shares as on October 31, 2025. Further, the Notice to shareholders with respect to special window open for re-lodgement of transfer request of physical shares for a period of six months from July 7, 2025 till January 6, 2026 is available at the website of the Company at www.krebsbiochem.com.
The above information is a part of company’s filings submitted to BSE.
